Detection of ovarian tumors in chicken by sonography: A step toward early diagnosis in humans?

Journal of Ultrasound in Medicine

Volumn 26, Issue 7, 2007, Pages 909-919

  Barua, Animesh ^a   Abramowicz, Jacques S ^a   Bahr, Janice M ^b   Bitterman, Pincas ^a   Dirks, Angela ^b   Holub, Keith A ^c   Sheiner, Eyal ^d   Bradaric, Michael J ^a   Edassery, Seby L ^a   Luborsky, Judith L ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^c ZONARE Medical Systems Inc   (United States)

^d BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

Animal model; Laying hen; Ovarian cancer; Sonography

Indexed keywords

ANIMALS; BIOLOGICAL ORGANS; DIAGNOSIS; HISTOLOGY; ULTRASONOGRAPHY;

ANIMAL MODELS; BLOOD FLOW; OVARIAN CANCER; PULSATILITY INDEX;

TUMORS;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD FLOW VELOCITY; CHICKEN; COLOR ULTRASOUND FLOWMETRY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; ECHOGRAPHY; FEMALE; FUNCTIONAL ANATOMY; GRAY SCALE ECHOGRAPHY; HISTOPATHOLOGY; NONHUMAN; OVARY CANCER; OVARY TUMOR; TRANSVAGINAL ECHOGRAPHY; TUMOR DIAGNOSIS; UTERUS BLOOD FLOW;

EID: 34447118782     PISSN: 02784297     EISSN: None     Source Type: Journal    
DOI: 10.7863/jum.2007.26.7.909     Document Type: Article

References (44)

1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2006. CA Cancer J Clin 2006; 56:106-130.
2. Dimascio J, Schilder RJ. Early stage management. In: Ozols RF (ed). Ovarian Cancer: ACS Atlas of Clinical Oncology. Hamilton, Ontario, Canada: BC Decker Inc; 2002: 147-158.
3. Jacobs IJ, Menon U. Progress and challenges in screening for early detection of ovarian cancer. Mol Cell Proteomics 2004; 3:355-366.
4. Rose NR. Avian models of autoimmune disease: lessons from the birds. Poult Sci 1994; 73:984-990.
5. Sundick RS, Bagchi N, Brown TR. The obese strain chicken as a model for human Hashimoto's thyroiditis. Exp Clin Endocrinol Diabetes 1996; 104(suppl 3):4-6.
6. Vanderhyden BC, Shaw TJ, Ethier JF. Animal models of ovarian cancer. Reprod Biol Endocrinol 2003; 1:67.
7. Stakleff KD, Von Gruenigen VE. Rodent models for ovarian cancer research. Int J Gynecol Cancer 2003; 13: 405-412.
8. Fredrickson TN. Ovarian tumors of the hen. Environ Health Perspect 1987; 73:35-51.
9. Rodriguez-Burford C, Barnes MN, Berry W, Partridge EE, Grizzle WE. Immunohistochemical expression of molecular markers in an avian model: a potential model for preclinical evaluation of agents for ovarian cancer chemoprevention. Gynecol Oncol 2001; 81:373-379.
10. Damjanov I. Ovarian tumours in laboratory and domestic animals. Curr Top Pathol 1989; 78:1-10.
11. Giles JR, Shivaprasad HL, Johnson PA. Ovarian tumor expression of an oviductal protein in the hen: a model for human serous ovarian adenocarcinoma. Gynecol Oncol 2004; 95:530-533.
12. Johnson PA, Giles JR. Use of genetic strains of chickens in studies of ovarian cancer. Poult Sci 2006; 85:246-250.
13. Giles JR, Olson LM, Johnson PA. Characterization of ovarian surface epithelial cells from the hen: a unique model for ovarian cancer. Exp Biol Med (Maywood) 2006; 231: 1718-1725.
14. Bourne TH, Campbell S, Reynolds KM, et al. Screening for early familial ovarian cancer with transvaginal ultrasonography and colour blood flow imaging. BMJ 1993; 306: 1025-1029.
15. Jacobs IJ, Skates SJ, MacDonald N, et al. Screening for ovarian cancer: a pilot randomised controlled trial. Lancet 1999; 353:1207-1210.
16. Kurjak A, Prka M, Arenas JM, et al. Three-dimensional ultrasonography and power Doppler in ovarian cancer screening of asymptomatic peri- and postmenopausal women. Croat Med J 2005; 46:757-764.
17. Bosse K, Rhiem K, Wappenschmidt B, et al. Screening for ovarian cancer by transvaginal ultrasound and serum CA125 measurement in women with a familial predisposition: a prospective cohort study. Gynecol Oncol 2006; 103:1077-1082.
18. Creasman WT, DiSaia PJ. Screening in ovarian cancer. Am J Obstet Gynecol 1991; 165:7-10.
19. Olivier RI, Lubsen-Brandsma MA, Verhoef S, van Beurden M. CA125 and transvaginal ultrasound monitoring in high-risk women cannot prevent the diagnosis of advanced ovarian cancer. Gynecol Oncol 2006; 100:20-26.
20. Fishman DA, Cohen L, Blank SV, et al. The role of ultrasound evaluation in the detection of early-stage epithelial ovarian cancer. Am J Obstet Gynecol 2005; 192:1214-1221.
21. van Nagell JR Jr, DePriest PD, Reedy MB. The efficacy of transvaginal sonographic screening in asymptomatic women at risk for ovarian cancer. Gynecol Oncol 2000; 77:350-356.
22. Kinkel K, Hricak H, Lu Y, Tsuda K, Filly RA. US characterization of ovarian masses: a meta-analysis. Radiology 2000; 217:803-811.
23. Melnychuk VL, Cooper MW, Kirby JD, Rorie RW, Anthony NB. Use of ultrasonography to characterize ovarian status in chicken. Poult Sci 2002; 81:892-895.
24. Alcazar JL, Galan MJ, Garcia-Manero M, Guerriero S. Three-dimensional sonographic morphologic assessment in complex adnexal masses: preliminary experience. J Ultrasound Med 2003; 22:249-254.
25. Alcazar JL, Ruiz-Perez ML, Errasti T. Transvaginal color Doppler sonography in adnexal masses: which parameter performs best? Ultrasound Obstet Gynecol 1996; 8:114-119.
26. Classification and staging of malignant tumours in the female pelvis. Acta Obstet Gynecol Scand 1971; 50:1-7.
27. Bronneberg RG, Taverne MA. Ultrasonography of the female reproductive organs in farmed ostriches (Struthio camelus spp). Theriogenology 2003; 60:617-633.
28. Rawlings NC, Evans AC, Honaramooz A, Bartlewski PM. Antral follicle growth and endocrine changes in prepubertal cattle, sheep and goats. Anim Reprod Sci 2003; 78:259-270.
29. Mendelson EB, Bohm-Velez M, Joseph N, Neiman HL. Gynecologic imaging: comparison of transabdominal and transvaginal sonography. Radiology 1988; 166:321-324.
30. Benacerraf BR, Finkler NJ, Wojciechowski C, Knapp RC. Sonographic accuracy in the diagnosis of ovarian masses. J Reprod Med 1990; 35:491-495.
31. Kurtz AB, Tsimikas JV, Tempany CM, et al. Diagnosis and staging of ovarian cancer: comparative values of Doppler and conventional US, CT, and MR imaging correlated with surgery and histopathologic analysis - report of the Radiology Diagnostic Oncology Group. Radiology 1999; 212:19-27.
32. Tung KH, Goodman MT, Wu AH, et al. Reproductive factors and epithelial ovarian cancer risk by histologic type: a multiethnic case-control study. Am J Epidemiol 2003; 158:629-638.
33. Kurjak A, Zalud I, Jurkovic D, Alfirevic Z, Miljan M. Transvaginal color Doppler for the assessment of pelvic circulation. Acta Obstet Gynecol Scand 1989; 68:131-135.
34. Bourne T, Campbell S, Steer C, Whitehead MI, Collins WP. Transvaginal colour flow imaging: a possible new screening technique for ovarian cancer. BMJ 1989; 299:1367-1370.
35. Benacerraf BR, Benson CB, Abuhamad AZ, et al. Three-and 4-dimensional ultrasound in obstetrics and gynecology: proceedings of the American Institute of Ultrasound in Medicine consensus conference. J Ultrasound Med 2005; 24:1587-1597.
36. Varras M. Benefits and limitations of ultrasonographic evaluation of uterine adnexal lesions in early detection of ovarian cancer. Clin Exp Obstet Gynecol 2004; 31:85-98.
37. Ueland FR, DePriest PD, Pavlik EJ, Kryscio RJ, van Nagell JR Jr. Preoperative differentiation of malignant from benign ovarian tumors: the efficacy of morphology indexing and Doppler flow sonography. Gynecol Oncol 2003; 91:46-50.
38. Itakura T, Kikkawa F, Kajiyama H, Mitsui T, Kawai M, Mizutani S. Doppler flow and arterial location in ovarian tumors. Int J Gynaecol Obstet 2003; 83:277-283.
39. Munkarah A, Chatterjee M, Tainsky MA. Update on ovarian cancer screening. Curr Opin Obstet Gynecol 2007; 19:22-26.
40. Kurjak A, Kupesic-Urek S, Schulman H, Zalud I. Transvaginal color flow Doppler in the assessment of ovarian and uterine blood flow in infertile women. Fertil Steril 1991; 56:870-873.
41. Brown DL, Frates MC, Laing FC, et al. Ovarian masses: can benign and malignant lesions be differentiated with color and pulsed Doppler US? Radiology 1994; 190:333-336.
42. Hamper UM, Sheth S, Abbas FM, Rosenshein NB, Aronson D, Kurman RJ. Transvaginal color Doppler sonography of adnexal masses: differences in blood flow impedance in benign and malignant lesions. AJR Am J Roentgenol 1993; 160:1225-1228.
43. Orden MR, Jurvelin JS, Kirkinen PP. Kinetics of a US contrast agent in benign and malignant adnexal tumors. Radiology 2003; 226:405-410.
44. Abramowicz JS. Ultrasonographic contrast media: has the time come in obstetrics and gynecology? J Ultrasound Med 2005; 24:517-531.